Gordana Konjevic
Overview
Explore the profile of Gordana Konjevic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Radenkovic S, Konjevic G, Nikitovic M, Stojanovic Rundic S, Karapandzic V, Milovic Kovacevic M, et al.
J BUON
. 2021 Jun;
26(2):475-482.
PMID: 34076995
Purpose: Considering that cyclin D1 had a prognostic and clinical value for breast cancer patients, adequate measurement of cyclin D1 is necessary. Methods: In this investigation, we detect cyclin D1...
2.
Mirjacic Martinovic K, Milicevic M, Larsen A, Dzodic R, Jurisic V, Konjevic G, et al.
Eur Cytokine Netw
. 2020 Feb;
30(4):160-167.
PMID: 32096478
Objective: Stage II melanoma patients have high risk for regional and distant metastases and may benefit from novel therapeutic strategies. To clarify the role of NK cells in Stage II...
3.
Radenkovic S, Konjevic G, Gavrilovic D, Stojanovic-Rundic S, Plesinac-Karapandzic V, Stevanovic P, et al.
Pathol Res Pract
. 2019 Jan;
215(2):366-372.
PMID: 30598340
Background: Constitutive activation of STAT3 have been shown in several tumor types including breast cancer. We investigate STAT3 expresion as possible molecular marker for breast cancer early detection, as well...
4.
Vuletic A, Jovanic I, Jurisic V, Milovanovic Z, Nikolic S, Spurnic I, et al.
Pathol Oncol Res
. 2018 Jun;
26(1):223-231.
PMID: 29948616
Regional lymph nodes (LN)s represent important immunological barriers in spreading of malignant tumors. However, they are the most frequent early metastatic site in melanoma. Immunomodulatory agents including cytokines have been...
5.
Konjevic G, Vuletic A, Mirjacic Martinovic K, Krivokuca A, Jankovic R, Babovic N
J Membr Biol
. 2017 Sep;
250(5):507-516.
PMID: 28887642
NK cells of metastatic melanoma (MM) patients display impaired function, making them incapable to mount an effective antitumor response. In this study, we evaluated immunophenotypic characteristics and functional capacity of...
6.
Konjevic G, Vuletic A, Mirjacic Martinovic K, Colovic N, Colovic M, Jurisic V
J Clin Pathol
. 2016 Apr;
PMID: 27083212
Aim: As innate immune cells natural killer (NK), NK-like T and CTLγδ are important in antitumour response in multiple myeloma (MM), the aim of this study was to investigate some...
7.
Jurisic V, Radenkovic S, Konjevic G
Adv Exp Med Biol
. 2015 Nov;
867:115-24.
PMID: 26530363
Lactate dehydrogenase (LDH) among many biochemical parameters represents a very valuable enzyme in patients with cancer with possibility for easy routine measurement in many clinical laboratories. Previous studies where mostly...
8.
Mirjacic Martinovic K, Srdic-Rajic T, Babovic N, Dzodic R, Jurisic V, Konjevic G
J Clin Pathol
. 2015 Oct;
69(4):300-6.
PMID: 26442832
Aims: As numerous signalling molecules regulate effector functions of peripheral blood lymphocytes (PBLs) that have an important anti-tumour activity, the aim of this study was to analyse their level in...
9.
Konjevic G, Vuletic A, Mirjacic Martinovic K
Immunol Res
. 2015 Sep;
64(1):25-35.
PMID: 26374324
Numerous newly identified activating and inhibitory NK cell receptors and their engagement by cognate ligands on target tumor cells regulate NK cell antitumor activity. Alterations in NK cell receptor expression...
10.
Vuletic A, Jovanic I, Jurisic V, Milovanovic Z, Nikolic S, Spurnic I, et al.
Pathol Oncol Res
. 2015 May;
21(4):1109-14.
PMID: 25933640
As lymphogenic dissemination is very common in melanoma, regional lymph nodes (LN)s represent first immunological barriers to tumor invasion and play a complex role in antitumor immune defense. In this...